Novo Nordisk to Invest ~$117.4M in Expansion of its Production Facilities in Denmark

 Novo Nordisk to Invest ~$117.4M in Expansion of its Production Facilities in Denmark

Novo Nordisk to Invest ~$117.4M in Expansion of its Production Facilities in Denmark

Shots:

  • Novo Nordisk to invest $117.4M in upgrading and expanding facilities at its production site in Kalundborg, Denmark
  • The facilities currently develop diabetic therapies and will be rebuilt and expanded for the future production of these and the next generation of diabetic therapies. The projects are expected to be completed in 2022
  • The investment in production facilities will strengthen its presence in Denmark and Kalundborg

Click here ­to­ read full press release/ article | Ref: Novo Nordisk | Image: New Age

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post